{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T15:43:54Z","timestamp":1788536634858,"version":"build-2803163510"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":427,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"abstract":"\n \n \n Activation of the renin angiotensin system resulting in stimulation of angiotensin-II (AngII) type I receptor (AT1R) is an important factor in the development of liver fibrosis. Here, we investigated the role of Janus kinase 2 (JAK2) as a newly described intracellular effector of AT1R in mediating liver fibrosis. Fibrotic liver samples from rodents and humans were compared to respective controls. Transcription, protein expression, activation, and localization of JAK2 and downstream effectors were analyzed by real-time polymerase chain reaction, western blotting, immunohistochemistry, and confocal microscopy. Experimental fibrosis was induced by bile duct ligation (BDL), CCl4 intoxication, thioacetamide intoxication or continuous AngII infusion. JAK2 was inhibited by AG490.<\/jats:bold>\n \n In vitro\n <\/jats:bold>\n experiments were performed with primary rodent hepatic stellate cells (HSCs), Kupffer cells (KCs), and hepatocytes as well as primary human and human-derived LX2 cells. JAK2 expression and activity were increased in experimental rodent and human liver fibrosis, specifically in myofibroblastic HSCs. AT1R stimulation in wild-type animals led to activation of HSCs and fibrosis<\/jats:bold>\n \n in vivo\n <\/jats:bold>\n through phosphorylation of JAK2 and subsequent RhoA\/Rho-kinase activation. These effects were prevented in AT1R\u2212\/\u2212 mice. Pharmacological inhibition of JAK2 attenuated liver fibrosis in rodent fibrosis models.<\/jats:bold>\n \n In vitro\n <\/jats:bold>\n , JAK2 and downstream effectors showed increased expression and activation in activated HSCs, when compared to quiescent HSCs, KCs, and hepatocytes isolated from rodents. In primary human and LX2 cells, AG490 blocked AngII-induced profibrotic gene expression. Overexpression of JAK2 led to increased profibrotic gene expression in LX2 cells, which was blocked by AG490.<\/jats:bold>\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion :<\/jats:title>\n \n Our study substantiates the important cell-intrinsic role of JAK2 in HSCs for development of liver fibrosis. Inhibition of JAK2 might therefore offer a promising therapy for liver fibrosis. (Hepatology 2014;60:334\u2013348)<\/jats:bold>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1002\/hep.27117","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T10:14:53Z","timestamp":1394532893000},"page":"334-348","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":115,"title":["Angiotensin-II Type 1 Receptor-Mediated Janus Kinase 2 Activation Induces Liver Fibrosis"],"prefix":"10.1097","volume":"60","author":[{"given":"Michaela","family":"Granzow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schierwagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benita","family":"Kowallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Huss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irela G. Reza","family":"Mazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"G\u00f6rtzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank A.","family":"Schildberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Gonzalez-Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Wojtalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Nattermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren V.","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter O.","family":"F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Laleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percy","family":"Knolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Sauerbruch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-38-20250207","doi-asserted-by":"crossref","first-page":"209218","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis.","volume":"115","author":"Bataller","year":"2005","journal-title":"J Clin Invest"},{"key":"R3-38-20250207","doi-asserted-by":"crossref","first-page":"16551669","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis.","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"R4-38-20250207","doi-asserted-by":"crossref","first-page":"7699","DOI":"10.1111\/j.1582-4934.2006.tb00292.x","article-title":"Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGFbeta as major players and therapeutic targets.","volume":"10","author":"Gressner","year":"2006","journal-title":"J Cell Mol Med"},{"key":"R5-38-20250207","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1016\/j.mam.2007.09.002","article-title":"Myofibroblastlike cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.","volume":"29","author":"Parola","year":"2008","journal-title":"Mol Aspects Med"},{"key":"R6-38-20250207","doi-asserted-by":"crossref","first-page":"13831394","DOI":"10.1172\/JCI18212","article-title":"NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis.","volume":"112","author":"Bataller","year":"2003","journal-title":"J Clin Invest"},{"key":"R7-38-20250207","doi-asserted-by":"crossref","first-page":"11491156","DOI":"10.1016\/S0016-5085(00)70368-4","article-title":"Angiotensin II induces contraction and proliferation of human hepatic stellate cells.","volume":"118","author":"Bataller","year":"2000","journal-title":"Gastroenterology"},{"key":"R8-38-20250207","doi-asserted-by":"crossref","first-page":"773780","DOI":"10.1016\/S0168-8278(02)00307-0","article-title":"Hemodynamic and antifibrotic effects of losartan in rats with liver fibrosis andor portal hypertension.","volume":"37","author":"Croquet","year":"2002","journal-title":"J Hepatol"},{"key":"R9-38-20250207","doi-asserted-by":"crossref","first-page":"10461055","DOI":"10.1002\/hep.20665","article-title":"Systemic infusion of angiotensin II exacerbates liver fibrosis in bile ductligated rats.","volume":"41","author":"Bataller","year":"2005","journal-title":"Hepatology"},{"key":"R10-38-20250207","doi-asserted-by":"crossref","first-page":"317323","DOI":"10.1016\/j.jhep.2005.02.034","article-title":"Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice.","volume":"43","author":"Yang","year":"2005","journal-title":"J Hepatol"},{"key":"R11-38-20250207","doi-asserted-by":"crossref","first-page":"75607563","DOI":"10.3748\/wjg.v11.i48.7560","article-title":"Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study.","volume":"11","author":"Sookoian","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R12-38-20250207","doi-asserted-by":"crossref","first-page":"10061012","DOI":"10.1046\/j.1365-2362.2003.01251.x","article-title":"Acute haemodynamic effects of losartan in anaesthetized cirrhotic rats.","volume":"33","author":"Heller","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"R13-38-20250207","doi-asserted-by":"crossref","first-page":"657666","DOI":"10.1111\/j.1478-3231.2005.01053.x","article-title":"Vascular, hemodynamic and renal effects of lowdose losartan in rats with secondary biliary cirrhosis.","volume":"25","author":"Heller","year":"2005","journal-title":"Liver Int"},{"key":"R14-38-20250207","doi-asserted-by":"crossref","first-page":"141156","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension.","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"R15-38-20250207","doi-asserted-by":"crossref","first-page":"744749","DOI":"10.1136\/gut.2003.020263","article-title":"Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications.","volume":"53","author":"Benvegnu","year":"2004","journal-title":"Gut"},{"key":"R16-38-20250207","doi-asserted-by":"crossref","first-page":"C82C97","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system.","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"R17-38-20250207","doi-asserted-by":"crossref","first-page":"242253","DOI":"10.1002\/hep.21673","article-title":"Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoARhokinase and activation of endothelial nitric oxide synthase.","volume":"46","author":"Trebicka","year":"2007","journal-title":"Hepatology"},{"key":"R18-38-20250207","doi-asserted-by":"crossref","first-page":"19241935","DOI":"10.1002\/hep.23222","article-title":"Role of beta3adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis.","volume":"50","author":"Trebicka","year":"2009","journal-title":"Hepatology"},{"key":"R19-38-20250207","doi-asserted-by":"crossref","first-page":"702712","DOI":"10.1016\/j.jhep.2010.04.025","article-title":"Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.","volume":"53","author":"Trebicka","year":"2010","journal-title":"J Hepatol"},{"key":"R20-38-20250207","doi-asserted-by":"crossref","first-page":"12201227","DOI":"10.1016\/j.jhep.2012.07.033","article-title":"HSCspecific inhibition of Rhokinase reduces portal pressure in cirrhotic rats without major systemic effects.","volume":"57","author":"Klein","year":"2012","journal-title":"J Hepatol"},{"key":"R21-38-20250207","doi-asserted-by":"crossref","first-page":"183190","DOI":"10.1038\/nm.2079","article-title":"The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure.","volume":"16","author":"Guilluy","year":"2010","journal-title":"Nat Med"},{"key":"R22-38-20250207","doi-asserted-by":"crossref","first-page":"50475056","DOI":"10.3748\/wjg.v16.i40.5047","article-title":"Daily genetic profiling indicates JAKSTAT signaling promotes early hepatic stellate cell transdifferentiation.","volume":"16","author":"Lakner","year":"2010","journal-title":"World J Gastroenterol"},{"key":"R23-38-20250207","doi-asserted-by":"crossref","first-page":"20162026","DOI":"10.1002\/hep.22560","article-title":"Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells.","volume":"48","author":"De Minicis","year":"2008","journal-title":"Hepatology"},{"key":"R24-38-20250207","doi-asserted-by":"crossref","first-page":"991999","DOI":"10.1016\/j.jhep.2009.09.008","article-title":"A novel model of CCl4induced cirrhosis with ascites in the mouse.","volume":"51","author":"Domenicali","year":"2009","journal-title":"J Hepatol"},{"key":"R25-38-20250207","doi-asserted-by":"crossref","first-page":"242249","DOI":"10.1111\/j.1365-2362.2006.01620.x","article-title":"A stable model of cirrhotic portal hypertension in the rat: thioacetamide revisited.","volume":"36","author":"Laleman","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"R26-38-20250207","doi-asserted-by":"crossref","first-page":"470474","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation.","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat Med"},{"key":"R27-38-20250207","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-3-10","article-title":"Development and evaluation of an open source Delphibased software for morphometric quantification of liver fibrosis.","volume":"3","author":"Huss","year":"2011","journal-title":"Fibrogenesis Tissue Repair"},{"key":"R28-38-20250207","doi-asserted-by":"crossref","first-page":"862872","DOI":"10.1111\/j.1478-3231.2011.02496.x","article-title":"Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB(2) receptordeficient mice and decreased in CB(1) receptor knockouts.","volume":"31","author":"Trebicka","year":"2011","journal-title":"Liver Int"},{"key":"R29-38-20250207","doi-asserted-by":"crossref","first-page":"G873G887","DOI":"10.1152\/ajpgi.00241.2011","article-title":"The endocannabinoid Narachidonoyl dopamine (NADA) selectively induces oxidative stressmediated cell death in hepatic stellate cells, but not in hepatocytes.","volume":"302","author":"Wojtalla","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R30-38-20250207","doi-asserted-by":"crossref","first-page":"13751382","DOI":"10.1038\/labinvest.2011.78","article-title":"Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via tolllike receptor 2.","volume":"91","author":"Coenen","year":"2011","journal-title":"Lab Invest"},{"key":"R31-38-20250207","doi-asserted-by":"crossref","first-page":"967977","DOI":"10.1038\/labinvest.2012.54","article-title":"NK cells from HCVinfected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL, FasL and NKG2Ddependent manner.","volume":"92","author":"Glassner","year":"2012","journal-title":"Lab Invest"},{"key":"R32-38-20250207","doi-asserted-by":"crossref","first-page":"671679","DOI":"10.1053\/j.gastro.2008.04.010","article-title":"Plateletderived growth factor signaling through ephrinb2 regulates hepatic vascular structure and function.","volume":"135","author":"Semela","year":"2008","journal-title":"Gastroenterology"},{"key":"R33-38-20250207","doi-asserted-by":"crossref","first-page":"14401450","DOI":"10.1038\/labinvest.2012.106","article-title":"Atorvastatin induces senescence in activated hepatic stellate cells and attenuates hepatic fibrosis in rats.","volume":"92","author":"Klein","year":"2012","journal-title":"Lab Invest"},{"key":"R34-38-20250207","doi-asserted-by":"crossref","first-page":"12731292","DOI":"10.1111\/j.1476-5381.2010.00750.x","article-title":"Reninangiotensinaldosterone system blockade for cardiovascular diseases: current status.","volume":"160","author":"Ma","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R35-38-20250207","first-page":"49935005","article-title":"Novel aspects of the reninangiotensinaldosteronesystem.","volume":"13","author":"Wolf","year":"2008","journal-title":"Front Biosci"},{"key":"R36-38-20250207","doi-asserted-by":"crossref","first-page":"465468","DOI":"10.1016\/j.biocel.2011.11.019","article-title":"Angiotensin signalling in pulmonary fibrosis.","volume":"44","author":"Uhal","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"R37-38-20250207","doi-asserted-by":"crossref","first-page":"G147G156","DOI":"10.1152\/ajpgi.00462.2007","article-title":"Atorvastatin attenuates angiotensin IIinduced inflammatory actions in the liver.","volume":"296","author":"Moreno","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R38-38-20250207","doi-asserted-by":"crossref","first-page":"13001314","DOI":"10.1136\/gut.2007.144584","article-title":"Mechanisms of extrahepatic vasodilation in portal hypertension.","volume":"57","author":"Hennenberg","year":"2008","journal-title":"Gut"},{"key":"R39-38-20250207","doi-asserted-by":"crossref","first-page":"23342344.e1.e1","DOI":"10.1053\/j.gastro.2009.02.081","article-title":"Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis.","volume":"136","author":"Oakley","year":"2009","journal-title":"Gastroenterology"},{"key":"R40-38-20250207","doi-asserted-by":"crossref","first-page":"1027710288","DOI":"10.1074\/jbc.M111.317453","article-title":"Hepatocytespecific deletion of Janus kinase 2 (JAK2) protects against dietinduced steatohepatitis and glucose intolerance.","volume":"287","author":"Shi","year":"2012","journal-title":"J Biol Chem"},{"key":"R41-38-20250207","doi-asserted-by":"crossref","first-page":"14121423","DOI":"10.1172\/JCI42894","article-title":"Abrogation of growth hormone secretion rescues fatty liver in mice with hepatocytespecific deletion of JAK2.","volume":"121","author":"Sos","year":"2011","journal-title":"J Clin Invest"},{"key":"R42-38-20250207","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1476-4598-10-150","article-title":"IL17 induces AKTdependent IL6JAK2STAT3 activation and tumor progression in hepatocellular carcinoma.","volume":"10","author":"Gu","year":"2011","journal-title":"Mol Cancer"},{"key":"R43-38-20250207","doi-asserted-by":"crossref","first-page":"979988","DOI":"10.1002\/hep.24469","article-title":"Canonical notch pathway protects hepatocytes from ischemiareperfusion injury in mice by repressing reactive oxygen species production through JAK2STAT3 signaling.","volume":"54","author":"Yu","year":"2011","journal-title":"Hepatology"},{"key":"R44-38-20250207","doi-asserted-by":"crossref","first-page":"600610","DOI":"10.1002\/lt.22036","article-title":"Blockade of Janus kinase2 signaling ameliorates mouse liver damage due to ischemia and reperfusion.","volume":"16","author":"Freitas","year":"2010","journal-title":"Liver Transpl"},{"key":"R45-38-20250207","doi-asserted-by":"crossref","first-page":"11171127","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis.","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N Engl J Med"},{"key":"R46-38-20250207","doi-asserted-by":"crossref","first-page":"574582","DOI":"10.1016\/j.tips.2012.08.005","article-title":"JAK2 the future: therapeutic strategies for JAKdependent malignancies.","volume":"33","author":"Lafave","year":"2012","journal-title":"Trends Pharmacol Sci"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.27117","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201407000-00038","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:08:31Z","timestamp":1738948111000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201407000-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.27117","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}